tirzepatide hypothyroidism Lots of questions regarding Thyroid and use of GLP1 meds. I discuss this and more in my book Weightless, you can preorder in the link in bio. #hashimoto #hashimotosdisease #glp1 #drsalaswhalen #weightlessthebook Tirzepatide with Hypothyroidism: Safety &

doi:10.3390/ijms19113425

These trials assessed the proportions of patients achieving single and composite endpoints, encompassing glycemic control [defined in terms of glycated hemoglobin (HbA1c)], weight loss, and hypoglycemia

Blood levels rise across the first several weekly doses and settle near steady state after about four weeks. That is why the four-week hold matters: the full effect of a dose change is not visible in the first few days

When semaglutide is stopped, appetite will increase

This effect lets you train harder and longer without fatigue, increasing your workout productivity and helping you break past performance plateaus.

Similar findings were observed in patients with and without a diagnosis of obesity. They added: These findings suggest the need for clinical trials to evaluate semaglutides potential for TUD treatment. In the past there have been reports of reduced desire to smoke in patients treated with semaglutide, which is also used to treat obesity, raising interest about its potential benefit for use in helping people stop smoking